This predicted cell cycle promoting activity of HIF-2α is likely to be necessary for tumour formation in the Vhl/Trp53 background, but may become at least partly redundant due to the additional mutation of Rb1, which promotes the cell cycle by removing the negative regulation of E2F transcription factors. The gene discussed is RB1; the disease is neoplasm.